Laird Norton Trust Company, LLC Danaher Corp Transaction History

Laird Norton Trust Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $650,759 - $741,527	2,792 New	2,792 $692,000
Q2 2022 Aug 03, 2022	SELL	$237.11 - $299.66 $198,935 - $251,414	-839 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$257.27 - $315.76 $55,055 - $67,572	-214 Reduced 20.32%	839 $246,000
Q4 2021 Feb 07, 2022	SELL	$292.08 - $329.01 $5,549 - $6,251	-19 Reduced 1.77%	1,053 $346,000
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $10,616 - $12,964	-39 Reduced 3.51%	1,072 $326,000
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $30,835 - $37,221	-137 Reduced 10.98%	1,111 $298,000
Q4 2020 Feb 26, 2021	BUY	$212.5 - $245.46 $265,200 - $306,334	1,248 New	1,248 $277,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Laird Norton Trust Company, LLC with notifications on news.